×
Diabetes

VOGLIBITE-GM1/0.2 TAB


Rs 139.25 10 % Off


Package size

  • Rs 139.25
  • 10 Soft gelatin Capsules

    Estimate Delivery by: Tomorrow

    Delivering to 201301, Noida


    Easy 7 days return available

    Rs 139.25 10 % Off

    VOGLIBITE-GM1/0.2 TAB

    Voglibite GM 1 mg Tablets are designed to provide effective relief for symptoms associated with vestibular disorders and Meniere's disease. Each tablet combines 1 mg of Betahistine dihydrochloride with 40 mg of Ginkgo Biloba extract. Betahistine works by enhancing blood circulation in the inner ear, which helps to alleviate symptoms such as dizziness, vertigo, and tinnitus by stabilizing inner ear pressure. Ginkgo Biloba provides additional benefits by improving cognitive function and supporting peripheral circulation. This dual-action formula ensures comprehensive symptom management while supporting overall inner ear and cognitive health. The tablets are formulated for convenience, with a pack of 10 tablets ideal for both short-term relief and long-term use. Voglibite GM helps enhance the quality of life by addressing the underlying causes of vestibular symptoms and improving overall well-being.

    Product Highlights and Usage:

    Active Ingredients: Each tablet contains 1 mg of Betahistine dihydrochloride and 40 mg of Ginkgo Biloba extract, offering a combination of therapeutic effects. Dual Action: Combines Betahistine to improve blood flow in the inner ear and reduce dizziness, vertigo, and tinnitus, with Ginkgo Biloba to support cognitive function and peripheral circulation. Symptom Relief: Effective in managing symptoms related to vestibular disorders and Meniere's disease. Convenient Tablet Form: Presented in an easy-to-swallow tablet form for precise dosing and ease of daily use. 10-Tablet Pack: Supplied in a pack of 10 tablets, suitable for both short-term use and long-term management.

    How it works:

    VOGLIBITE GM 1MG TABLET is used to manage type 2 diabetes mellitus. Glimepiride helps lower blood glucose levels by increasing insulin release from the pancreas. Metformin reduces glucose production in the liver and decreases glucose absorption in the stomach and intestines. It also improves the body’s response to insulin. Voglibose works by inhibiting the alpha-glucosidase enzyme, which breaks down complex carbohydrates into simple sugars. This action slows the digestion and absorption of carbohydrates in the small intestine, leading to reduced blood glucose levels in individuals with type 2 diabetes mellitus.

    Directions for use:

    Take VOGLIBITE GM 1MG TABLET as directed by your physician. Swallow the tablet with a glass of water; do not crush or chew it. Your doctor will determine the appropriate dose and duration based on your age, body weight, and medical condition.

    Warning & Precaution:

    PREGNANCY VOGLIBITE GM 1MG TABLET is not recommended during pregnancy as it may harm the fetus. Consult your doctor before use. BREASTFEEDING VOGLIBITE GM 1MG TABLET is not recommended for breastfeeding women, as it may pass into breast milk and affect the nursing child. Consult your doctor before use. DRIVING AND USING MACHINES Use VOGLIBITE GM 1MG TABLET with caution if you experience reduced alertness or reactions due to hypoglycemia. Avoid driving or operating machinery if you notice these symptoms. ALCOHOL Consult your doctor before consuming alcohol while taking VOGLIBITE GM 1MG TABLET, as it may lower your blood sugar levels. KIDNEY VOGLIBITE GM 1MG TABLET is not recommended for patients with severe kidney failure and should be used with caution in those with other kidney conditions. Consult your doctor before use. LIVER VOGLIBITE GM 1MG TABLET is not recommended for patients with severe liver disease and should be used with caution in those with other liver conditions. Consult your doctor before use. ALLERGY Do not use VOGLIBITE GM 1MG TABLET if you are allergic to glimepiride, metformin, voglibose, other sulfonylureas, sulphonamides, or any other ingredients in this medicine. LUNGS VOGLIBITE GM 1MG TABLET is not recommended for patients with lung conditions such as acute or chronic respiratory failure. Consult your doctor before use. HEART DISEASE VOGLIBITE GM 1MG TABLET is not recommended for patients with heart problems, including recent heart attack, chronic heart failure, or cardiogenic shock. Consult your doctor before use. USE IN PEDIATRICS VOGLIBITE GM 1MG TABLET is not recommended for children and adolescents under 18 years due to insufficient data on its safety and effectiveness. Consult your doctor before use. USE IN GERIATRICS Use VOGLIBITE GM 1MG TABLET with caution in elderly patients aged 65 and above. Consult your doctor before use.

    4.2
    Date

    Super Admin

    Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s

    medicare-logo-white

    APMEDCARE: Your digital partner in navigating secure, accessible healthcare services.

    Recent Posts

    Our services

    Copyright @ AXOLAB PHARMACEUTICALS PRIVATE LIMITED, 2025. All rights reserved.